Ethical Issues Associated With Routine Screening and Prophylaxis for Group B Streptococcus in Pregnancy
An increased awareness of the impact of group B streptococcus (GBS) infection on neonatal outcome has prompted several seemingly discordant committee recommendations. Intrapartum antibiotics are effective in reducing the risk of neonatal morbidity when administered to a colonized woman who has a cli...
Main Authors: | Michael K. Yancey, Anne Schuchat, Patrick Duff |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1996-01-01
|
Series: | Infectious Diseases in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/S1064744996000099 |
Similar Items
-
Group B Streptococcus (Streptococcus agalactiae) Screening During Pregnancy
by: Jahan Ara Saeed
Published: (2014-12-01) -
Unnecessary Workup of Asymptomatic Neonates in the Era of Group B Streptococcus Prophylaxis
by: Brad Buckler, et al.
Published: (2010-01-01) -
Group B Streptococcus Colonization in Pregnancy
by: BN Dissanayake, et al.
Published: (2015-04-01) -
Antenatal Screening for Group B Streptococcus in the Setting of Preterm Premature Rupture of Membranes: Empiric versus Culture-based Prophylaxis
by: Leena B. Mithal, et al.
Published: (2020-01-01) -
Intrapartum Group B Streptococcus Antibiotic Prophylaxis in Penicillin Allergic Pregnant Women
by: Nerlyne Desravines, et al.
Published: (2019-07-01)